For research use only. Not for therapeutic Use.
PF-06952229 (Cat.No:I015468) is a potent, selective and orally active TGFbR1 inhibitor. PF-06952229 specifically binds to TGFbR1 and prevents TGFbR1-mediated signal transduction. PF-06952229 is a promising antineoplastic agent for the study solid tumors, especifically metastatic breast cancer.
Catalog Number | I015468 |
CAS Number | 1801333-55-0 |
Molecular Formula | C₂₃H₂₄ClFN₄O₃ |
Purity | ≥95% |
Target | TGF-β Receptor |
Reference | [1]. Flavia Mercer Pernasetti, et al. Combinations of tgfb inhibitors and cdk inhibitors for the treatment of breast cancer. Patent WO2020058820A1. |